Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | CTSD | P07339 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5898437 | 0.88 | MAPT (0.46) | MMP3MAPTKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL29372113 | 0.86 | MAPT (0.46) | MAPTKDM4EALDH1A1SMN1; SMN2CTSD | |
| SCHEMBL10623233 | 0.86 | MAPT (0.46) | MAPTKDM4EALDH1A1SMN1; SMN2CTSD | |
| SCHEMBL56880 | 0.83 | SMN1; SMN2 (0.47) | MMP3MAPTKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL2770469 | 0.83 | TAS1R3 (0.42) | MMP3KDM4EALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL68727 | 0.81 | MAPT (0.46) | MAPTKDM4EALDH1A1SMN1; SMN2CTSD | |
| SCHEMBL31484246 | 0.81 | MAPT (0.46) | MAPTKDM4EALDH1A1SMN1; SMN2CTSD | |
| SCHEMBL979842 | 0.76 | CA12 (0.58) | MAPTKDM4EALDH1A1SMN1; SMN2CTSD | |
| SCHEMBL2772458 | 0.75 | ABCG2 (0.48) | MMP3MAPTKDM4EALDH1A1MEN1 | |
| SCHEMBL23535325 | 0.74 | CNR2 (0.43) | MMP3MAPTKDM4EALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024136-B2 | Ultra-fast curing scratch-resistant headlight restoration coating | ILLINOIS TOOL WORKS INC. (US) | 2024-07-02 | — | — | US | claimed |
| EP-4514304-B1 | DENTAL COMPOSITION CONTAINING A RESORCINOL OR CATECHOL MOIETY CONTAINING COMPONENT AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12577340-B2 | Storage stable two-component dual cure dental composition | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-17 | — | — | US | disclosed |
| US-20260028440-A1 | Curable Composition for Producing Transparent Orthodontic Attachments | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4629958-A1 | SURFACE-TREATED FILLER, DENTAL COMPOSITION CONTAINING SUCH A FILLER, PROCESS OF PRODUCTION AND USE THEREOF | Solventum Intellectual Properties Company (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4329704-B1 | INITIATOR SYSTEM WITH POLYMERIZABLE THIOUREA COMPONENT, DENTAL COMPOSITION AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-3880156-B1 | STORAGE STABLE TWO-COMPONENT DUAL CURE DENTAL COMPOSITION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-08-20 | — | — | EP | disclosed |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-07-24 | — | — | US | disclosed |
| EP-4580818-A1 | ONE COMPONENT, UV-CURED PRIMER MATERIAL FOR REPAIRING SURFACE IMPERFECTIONS | Illinois Tool Works Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-4558086-A1 | CURABLE COMPOSITION FOR PRODUCING TRANSPARENT ORTHODONTIC ATTACHMENTS | Solventum Intellectual Properties Company (US) | 2025-05-28 | — | — | EP | disclosed |
| WO-2015126865-A1 | ADHESIVE BONDING COMPOSITION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-08-27 | — | — | WO | disclosed |
| WO-2015034977-A1 | DENTAL COMPOSITION CONTAINING POLYOXOMETALATES, PROCESS OF PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-03-12 | — | — | WO | disclosed |
| US-20140329205-A1 | ONE COMPONENT SELF-ADHESIVE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2014-11-06 | — | — | US | disclosed |
| EP-2785307-A1 | ONE COMPONENT SELF-ADHESIVE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M Innovative Properties Company (US) | 2014-10-08 | — | — | EP | disclosed |
| WO-2013082337-A1 | ONE COMPONENT SELF-ADHESIVE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-06-06 | — | — | WO | disclosed |
| US-7049350-B2 | Polymerizable compound, polymerizable composition and cured product containing the compound | SHOWA DENKO K.K. (JP) | 2006-05-23 | — | — | US | disclosed |
| US-20040235980-A1 | Polymerizable compound, polymerizable composition and cured product containing the compound | SHOWA DENKO K.K. (JP) | 2004-11-25 | — | — | US | disclosed |
| WO-2003010124-A1 | POLYMERIZABLE COMPOUND, polymeRIZABLE COMPOSITION AND CURED PRODUCT CONTAINING THE COMPOUND | SHOWA DENKO K. K. (JP) | 2003-02-06 | — | — | WO | disclosed |
| US-4792632-A | ADDITION POLYMER PHOTOINITIATORS | ESPE FABRIK PHARMAZEUTISCHER PRAPARATE GMBH (DE) | 1988-12-20 | — | — | US | disclosed |
| US-4737593-A | PHOTOINITIATORS FOR ADDITION POLYMERIZATION; DENTISTRY | Fabrik Pharmazeutischer Praparate (DE) | 1988-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140329205-A1 | ONE COMPONENT SELF-ADHESIVE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | ESD, CAD, GSS | MMP3 4261/4885MAPT 486/4885KDM4E 2607/4885 |
| US-20260028440-A1 | Curable Composition for Producing Transparent Orthodontic Attachments | SMCHD1, SMC2, SMC1A | MMP3 2203/4885MAPT 185/4885KDM4E 458/4885 |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | GSDMD, PIGS, GANC | MMP3 469/4885MAPT 2591/4885KDM4E 3077/4885 |
| US-12577340-B2 | Storage stable two-component dual cure dental composition | GPX4, SSRP1, H1-0 | MMP3 4211/4885MAPT 1702/4885KDM4E 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.